The last five years have seen major developments in the neuroimaging and treatment of ADHD. At the end of this Institute, the participant has a better understanding of the multiple brain regions involved in ADHD and how they relate to behavior, understands the results of the long term follow up studies of children with ADHD, can discuss the effects of stimulants on growth and the cardiovascular system, can discuss the clinical use of new medications in the treatment of ADHD, and improves their ability to diagnose and treat problems of aggression, mood disorders, and depression in children with ADHD. Awareness of recent neuroimaging and clinical trials data, combined with discussion from experienced clinicians, informs and enhances the clinical practice of participants.
Wednesday, October 28, 2009: 6:30 AM-3:00 PM
Chair:
6:45 AM
2.1
Neuroimaging of ADHD: Where Are We Going?
Steven R. Pliszka, M.D.
University of Texas Health Science Center at San Antonio, San Antonio, TX
7:30 AM
2.2
Long Term Follow-up of the Multimodal Treatment Study of ADHD: Lessons for Clinicians
L. Eugene Arnold, M.D.
Ohio State University, Nisonger Center UCEDD, Sunbury, OH
Brooke Molina, Ph.D.
University of Pittsburgh School of Medicine, Pittsburgh, PA
James M. Swanson, Ph.D.
UCI Child Development Center, Irvine, CA
8:15 AM
2.3
Long Term Follow-up of the Multimodal Treatment Study of ADHD: Effects of Assigned Treatment and Self-Selected Medication Use on Ultimate Height, Weight, and BMI
James M. Swanson, Ph.D.
UCI Child Development Center, Irvine, CA
Helena Kraemer, Ph.D.
Annamarie Stehli, M.P.H.
University of California at Irvine, Irvine, CA
Timothy Wigal, Ph.D.
University of California at Irvine, Irvine, CA
Stephen Hinshaw, Ph.D.
University of California Deptartment of Psychiatry, Berkeley, CA
L. Eugene Arnold, M.D.
Ohio State University, Nisonger Center UCEDD, Sunbury, OH
Brooke Molina, Ph.D.
University of Pittsburgh School of Medicine, Pittsburgh, PA
Laurence L. Greenhill, M.D.
New York State Psychiatric Institute, Columbia University, New York, NY
9:15 AM
2.4
ADHD Treatment: Insights From Biological and Genetic Studies
James T. McCracken, M.D.
University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
10:45 AM
2.6
The Cardiovascular and Other Adverse Events Associated with Stimulant Treatment of Children and Adolescents with ADHD
Laurence L. Greenhill, M.D.
New York State Psychiatric Institute, Columbia University, New York, NY
12:30 PM
2.7
How to Tell ADHD and Pediatric Bipolar Disorder Apart
Mani Pavuluri, M.D., Ph.D.
Institute for Juvenile Research, University of Illinois at Chicago; Center for Cognitive Medicine, Chicago, IL
1:15 PM
2.8
Comorbid Depression in Youth with ADHD
W. Burleson Daviss, M.D.
University of Texas Health Science Center at San Antonio, San Antonio, TX
